Effects of Aldosterone Blockade in Murine Lupus Nephritis
Author Information
Author(s): Monrad Seetha U, Killen Paul D, Anderson Marc R, Bradke Amanda, Kaplan Mariana J
Primary Institution: University of Michigan Medical School
Hypothesis
What is the effect of aldosterone receptor blockade on the progression of nephritis in a murine lupus model?
Conclusion
Aldosterone receptor blockade is safe and well tolerated in progressive murine lupus nephritis, leading to decreased proteinuria, lower autoantibody levels, and reduced kidney damage.
Supporting Evidence
- Spironolactone-treated mice had lower levels of proteinuria compared to control mice.
- Treatment resulted in significantly lower serum levels of anti-ssDNA and anti-dsDNA antibodies.
- Histopathological analysis showed less severe glomerulonephritis in treated mice.
Takeaway
This study shows that a medicine called spironolactone can help mice with a type of kidney disease by making their kidneys hurt less and keeping them healthier.
Methodology
Female NZB/W F1 mice were treated with spironolactone or vehicle, and various health parameters were monitored over 36 weeks.
Limitations
The study was conducted in a murine model, which may not fully replicate human conditions.
Participant Demographics
Female NZB/W F1 mice, aged 11 weeks at the start of treatment.
Statistical Information
P-Value
0.03 for anti-ssDNA, 0.05 for anti-dsDNA
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website